Board meeting on 3 November 2026 to consider Q2 and half-year unaudited results
Board meeting scheduled for Tuesday, 3 November 2026.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Tuesday, 3 November 2026
- Venue
- registered office of the company
- Results Period
- second quarter and half year ended 30 September 2026
What was announced
The company has informed BSE and NSE that a meeting of its Board of Directors is scheduled to be held on Tuesday, 3 November 2026 at the registered office. The letter is signed by the Company Secretary and is titled as an intimation of a Board meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting details
- Date: Tuesday, 3 November 2026
- Place: registered office of the company
- Purpose stated: to consider and approve the unaudited financial result for the second quarter and half year ended 30 September 2026, along with the Auditor's Limited Review Report
- The notice also lists "any other business with the permission of Chairman" as a second item
The company signs off as Shukra Medtech Limited (Formerly known as Shukra Pharmaceuticals Limited), which is the name that appears on the exchange headline and subject line. The scrip code quoted is 524632 and the NSE symbol is SHUKRAPHAR.
What the agenda means
A quarterly result announcement is the company's regular report card for a three-month period. Here the Board is meeting to take on record the numbers for the three months from July to September 2026, and also for the combined six-month period ended on that date.
Along with the results, the Board will consider the Auditor's Limited Review Report. A limited review is the auditor's check of the quarterly figures; it is narrower in scope than a full annual audit.
How to read this kind of notice
- This is a meeting notice, not the results themselves. It tells you when the numbers are expected; the figures come in a separate update after the meeting.
- The notice does not contain any financial numbers, so there is nothing here to compare against earlier quarters.
- The scheduled date is the point at which the quarterly performance, margins, and any commentary from the company would usually become public.
- The outcome of the meeting, and whether the results are approved as proposed, would be known only from the subsequent disclosure.
For a retail investor
This is a routine calendar update from the company. It indicates that the September-quarter results are due to be taken up by the Board on 3 November 2026. The useful next step is to read the actual results update, which would carry the revenue, profit and other financial details for the quarter and half year.
Also from Shukra Pharmaceuticals
Board meeting rescheduled to 4 November 2026 to consider Q2 and half-year results
23 Oct 2026
MCA approves change of name; fresh Certificate of Incorporation issued
12 Oct 2026
Board approves allotment of 17,35,000 equity shares on conversion of warrants
6 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.